UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.927

Sortiert nach

Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis

British journal of pharmacology, 2010-02, Vol.159 (4), p.842-855

2010

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function

Current cancer drug targets, 2010-03, Vol.10 (2), p.155

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3269-3276

2004

Link zum Volltext

Verfügbarkeit prüfen

Recent clinical studies of the immunomodulatory drug (IMiD ) lenalidomide

British journal of cancer, 2005-09, Vol.93 (6), p.613-619

2005

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)

British journal of cancer, 2009-09, Vol.101 (5), p.803-812

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

British journal of cancer, 2004-03, Vol.90 (5), p.955-961

2004

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

The Prostate, 2012-06, Vol.72 (8), p.856-867

2012

Link zum Volltext

Verfügbarkeit prüfen

The evolution of thalidomide and its IMiD derivatives as anticancer agents

Nature reviews. Cancer, 2004-04, Vol.4 (4), p.314-322

2004

Link zum Volltext

Verfügbarkeit prüfen

The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival

British journal of cancer, 2006-05, Vol.94 (10), p.1412-1419

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of high dose N- Acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: A randomised placebo-controlled pilot study

Pulmonary pharmacology & therapeutics, 2024-03, Vol.84, p.102283-102283, Article 102283

2024

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme

British journal of pharmacology, 2006-11, Vol.149 (6), p.775-785

2006

Link zum Volltext

Verfügbarkeit prüfen

An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia

British journal of pharmacology, 2007-12, Vol.152 (8), p.1239-1247

2007

Link zum Volltext

Verfügbarkeit prüfen

Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro

Microvascular research, 2005, Vol.69 (1), p.56-63

2005

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide-derived immunomodulatory drugs as therapeutic agents

Expert opinion on biological therapy, 2004-12, Vol.4 (12), p.1963-1970

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of lenalidomide on hypoxia-induced HIF-1α signaling and the invasive phenotype in epithelial solid tumor cells

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e21056-e21056

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibition by lenalidomide of growth factor and hypoxia-induced signaling in endothelial and epithelial tumor cells, and effects within the tumor cell microenvironment

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14620-e14620

2009

Link zum Volltext

Verfügbarkeit prüfen

Correlation of tumoricidal activity of lenalidomide against hematologic tumor cells with cyclin D1/D2 expression and effect on tumor-suppressor gene upregulation

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8090-8090

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of NKG2D/DNAM-1 interaction with tumor cell ligands on the ability of lenalidomide to enhance ADCC of antibody-coated solid tumor cells

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e21008-e21008

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms underlying gemcitabine resistance in pancreatic cancer and restoration of sensitivity using lenalidomide

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13630-e13630

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of lenalidomide on the antiprostate cancer activity of docetaxel in vitro and in vivo

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13155-e13155

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of lenalidomide on the antiproliferative effect of gemcitabine against pancreatic tumor cells and on immune-mediated pancreatic cancer cell death

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14635-e14635

2009

Link zum Volltext

Verfügbarkeit prüfen

Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins

Infection and Immunity, 1978-11, Vol.22 (2), p.418-422

1978

Link zum Volltext

Verfügbarkeit prüfen

The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-α production with antitumor activity

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.951-959

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparative Evaluation of Body Composition in Medically Stable Elderly

Journal of the American Dietetic Association, 1997-10, Vol.97 (10), p.1105-1109

1997

Link zum Volltext

Verfügbarkeit prüfen

Education and Certification Influence the Nutrition and Management Knowledge of Long-Term-Care Foodservice Managers

Journal of the American Dietetic Association, 1999-05, Vol.99 (5), p.553-557

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.927

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.641)
Mit Volltextzugriff
(2.616)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis

Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function

Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma

Recent clinical studies of the immunomodulatory drug (IMiD ) lenalidomide

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

The evolution of thalidomide and its IMiD derivatives as anticancer agents

The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival

Evaluation of high dose N- Acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: A randomised placebo-controlled pilot study

Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme

An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia

Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro

Thalidomide-derived immunomodulatory drugs as therapeutic agents

Effect of lenalidomide on hypoxia-induced HIF-1α signaling and the invasive phenotype in epithelial solid tumor cells

Inhibition by lenalidomide of growth factor and hypoxia-induced signaling in endothelial and epithelial tumor cells, and effects within the tumor cell microenvironment

Correlation of tumoricidal activity of lenalidomide against hematologic tumor cells with cyclin D1/D2 expression and effect on tumor-suppressor gene upregulation

Influence of NKG2D/DNAM-1 interaction with tumor cell ligands on the ability of lenalidomide to enhance ADCC of antibody-coated solid tumor cells

Molecular mechanisms underlying gemcitabine resistance in pancreatic cancer and restoration of sensitivity using lenalidomide

Effect of lenalidomide on the antiprostate cancer activity of docetaxel in vitro and in vivo

Effect of lenalidomide on the antiproliferative effect of gemcitabine against pancreatic tumor cells and on immune-mediated pancreatic cancer cell death

Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins

The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-α production with antitumor activity

Comparative Evaluation of Body Composition in Medically Stable Elderly

Education and Certification Influence the Nutrition and Management Knowledge of Long-Term-Care Foodservice Managers

Suchergebnisse filtern